Effects of ulinastatin on inflammatory response and cognitive function after hip arthroplasty for the elderly patients with femoral neck fracture

European Review for Medical and Pharmacological Sciences

Volumn 22, Issue 4, 2018, Pages 1126-1132

  Ren, K W ^a   Shen, N ^a   Tang, J L ^b   Nong, L M ^c   Gu, Y Q ^d  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

^b Qidong People's Hospital   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cognitive function; Elderly; Femoral neck fracture; Hip arthroplasty; Inflammatory response; Ulinastatin

Indexed keywords

C REACTIVE PROTEIN; EPINEPHRINE; INTERLEUKIN 1; MALONALDEHYDE; NEURON SPECIFIC ENOLASE; NORADRENALIN; PROTEIN S100B; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; ULINASTATIN; AUTACOID; GLYCOPROTEIN; TRYPSIN INHIBITOR;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ELDERLY CARE; FEMALE; FEMORAL NECK FRACTURE; HARRIS HIP SCORE; HIP ARTHROPLASTY; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NORADRENALIN BLOOD LEVEL; OBSERVATIONAL STUDY; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WALKING; ANTIOXIDANT ACTIVITY; BLOOD; HIP REPLACEMENT; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; COGNITION; FEMALE; FEMORAL NECK FRACTURES; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATIENT DISCHARGE; TREATMENT OUTCOME; TRYPSIN INHIBITORS;

EID: 85042739879     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. LIAN XL, ZHANG YP, LI X, JING LD, CAIRANG ZM, GOU JQ. Exploration on the relationship between the elderly osteoporosis and cardiovascular disease risk factors. Eur Rev Med Pharmacol Sci 2017; 21: 4386-4390.
2. YANG B, GAO M, WANG K, JIANG Y, PENG Y, ZHANG H, YANG M, XIAO X. Intraintestinal administration of ulinastatin protects against sepsis by relieving intestinal damage. J Surg Res 2017; 211: 70-78.
3. CHEN Q, HU C, LIU Y, LIU Y, WANG W, ZHENG H, RONG L, JIA J, SUN S, YU C, LIU YM. Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: a randomized, double-blind, placebo-controlled, ascending-dose study. PLoS One 2017; 12: e177425.
4. MOGGIA E, KOTI R, BELGAUMKAR AP, FAZIO F, PEREIRA SP, DAVIDSON BR, GURUSAMY KS. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev 2017; 4: D11384.
5. YU Z, RAYILE A, ZHANG X, LI Y, ZHAO Q. Ulinastatin protects against lipopolysaccharide-induced cardiac microvascular endothelial cell dysfunction via downregulation of lncRNA MALAT1 and EZH2 in sepsis. Int J Mol Med 2017; 39: 1269-1276.
6. LIU DH, YAO YT, LI LH, HUANG CM. Effects of ulinastatin on in vitro storage lesions of human red blood cells. Clin Lab 2017; 63: 833-838.
7. ABHYANKAR SV, VARTAK AM. Impact of ulinastatin on outcomes in acute burns patients. J Burn Care Res 2017 Apr 3. doi: 10.1097/BCR.0000000000000546. [Epub ahead of print]
8. PAN Y, FANG H, LU F, PAN M, CHEN F, XIONG P, YAO Y, HUANG H. Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells. J Inflamm (Lond) 2017; 14: 7.
9. WEI F, LIU S, LUO L, GU N, ZENG Y, CHEN X, XU S, ZHANG D. Anti-inflammatory mechanism of ulinastatin: inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-alpha via the RhoA/ROCK signal pathway. Int Immunopharmacol 2017; 46: 220-227.
10. LIU D, YU Z, YIN J, CHEN Y, ZHANG H, FAN X, FU H, WAN B. Effect of ulinastatin combined with thymosin alpha1 on sepsis: a systematic review and meta-analysis of Chinese and Indian patients. J Crit Care 2017; 39: 285-287.
11. NAKAMURA M, TAKEUCHI T, KAWAHARA T, HIROSE J, NAKAYAMA K, HOSAKA Y, FURUSAKO S. Simultaneous targeting of CD14 and factor XIa by a fusion protein consisting of an anti-CD14 antibody and the modified second domain of bikunin improves survival in rabbit sepsis models. Eur J Pharmacol 2017; 802: 60-68.
12. ZHOU X, YE Y, TANG G, WU F. "Small-study effects" in meta-analysis should not be ignored. J Crit Care 2017; 39: 283-284.
13. LI X, SU L, ZHANG X, ZHANG C, WANG L, LI Y, ZHANG Y, HE T, ZHU X, CUI L. Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia/reperfusion injury. Neurol Res 2017; 39: 367-373.
14. TAO Z, HU FQ, LI CF, ZHANG T, CAO BZ, CUI LQ. Effect of ulinastatin, a human urinary protease inhibitor, on heatstroke-induced apoptosis and inflammatory responses in rats. Exp Ther Med 2017; 13: 335-341.
15. QIAN ZY, YANG MF, ZUO KQ, XIAO HB, DING WX, CHENG J. Protective effects of ulinastatin on intestinal injury during the perioperative period of acute superior mesenteric artery ischemia. Eur Rev Med Pharmacol Sci 2014; 18: 3726-3732.
16. LUO Y, CHE W, ZHAO M. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells. Int J Mol Med 2017; 39: 297-306.
17. FAN H, ZHAO Y, ZHU JH, YE JH, YAO XQ. Ulinastatin and thymosin a1 therapy in adult patients with severe sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Iran J Public Health 2016; 45: 1234-1235.
18. LIU M, SHEN J, ZOU F, ZHAO Y, LI B, FAN M. Effect of ulinastatin on the permeability of the blood-brain barrier on rats with global cerebral ischemia/reperfusion injury as assessed by MRI. Biomed Pharmacother 2017; 85: 412-417.
19. WANG KY, YANG QY, TANG P, LI HX, ZHAO HW, REN XB. Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy. Metab Brain Dis 2017; 32: 427-435.
20. RU JY, XU HD, SHI D, PAN JB, PAN XJ, WANG YF. Blockade of NF-kappaB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo. Biosci Rep 2016; 36: 27-32.